Proqlea, a company founded in 2020, specializes in clinical trials and providing services in the pharmaceutical industry. However, behind its business success lies something much more important—a mission driven by a big heart.
Director Josipa Ljubičić has a strong desire to take concrete steps to improve the lives of those facing severe diagnoses. Her mission has been particularly shaped by the stories of patients suffering from rare and incurable diseases, which deeply moved her and motivated her to initiate change.
In addition to its professional successes, Proqlea has received two prestigious awards as the best micro-enterprise. In 2022 and 2023, they were awarded the title of “Family-Friendly Employer” by the Central State Office for Demography and Youth. These accolades are not just symbols of success but also affirm their commitment to creating a work environment that values family life.
Today, Proqlea employs 10 women, most of whom are mothers who have collectively given birth to 24 children. In Proqlea, children are not just a joy but also an inspiration for policies that reconcile work and private life.
Kindness is Medicine
The initiative Kindness is Medicine was launched by Josipa Ljubičić, the director of Proqlea, at the beginning of 2024.
It was initiated with the goal of increasing the availability of the latest therapies and medications for rare diseases in Croatia, thereby reducing the need for sick children and adults to travel abroad for experimental treatments.
- To awaken a sense of sympathy and solidarity towards those affected by rare diseases.
- To inform the public about clinical trials.
- The discovery and availability of new therapies – the last hope for many.
- Organization of panel discussions on clinical trials, the healthcare system, and the experiences and needs of people with rare diseases
- Organization of sports and entertainment events Many for the Rare
- Establishment of the platform www.klinickaispitivanja.hr
All information about clinical trials in one place:
- For experts, trial participants and curious laypeople
- News, updates, expert articles
- Answers to questions:
- How, when and where are they conducted?
- How to participate?
- How long do they last? How much do they cost?
- Interviews with patients, doctors
- Access to statistics
- Point-based training for doctors and pharmacists
- Newsletters
Construction of the EU Clinical Trial Incubator – a center for clinical trials (construction plan 2025-2029)
Benefits:
- Increased availability of medicines
Education of doctors - Research work available to students
- Relief of the healthcare system
- Involvement of pharmacies in conducting clinical trials
- Increase in the reputation of Croatia in clinical trials (Only 1% of EU clinical trials are conducted in Croatia)
- Increase in GDP
- Reduce the outflow of experts abroad
Many for the Rare
A sports and entertainment event to promote awareness of the importance of clinical trials.
Many for the Rare is not just a one-time event, but the beginning of a new tradition that will bring the community together every year in support of those suffering from rare diseases, and will become a symbol of unity and support for those who need it most.
Revenue from registration fees for participation in the race, as well as funds raised through donations, will be directed to support those suffering from rare diseases through local NGOs and initiatives that address this important issue.
Media corner
